| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-19 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-07 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |